Literature DB >> 4039705

Inhibition of serum bactericidal reaction by lipopolysaccharide.

M Sansano, A M Reynard, R K Cunningham.   

Abstract

An Rc-mutant of Escherichia coli that lacks UDPgalactose 4-epimerase grows normally without galactose but makes lipopolysaccharide lacking most of its carbohydrate. Exogenous galactose overrides the mutation and results in the formation of a complete lipopolysaccharide, thereby producing a smooth phenocopy. The smooth phenocopy was much more resistant to the bactericidal activity of normal human serum than was the rough phenotype. More complement was utilized by the rough mutant in the bactericidal process than by the smooth phenocopy. An antiserum was prepared in rabbits to a specific outer membrane protein in the mutant bacterium, the lambda receptor, whose expression could be suppressed by the addition of 10 mM maltose. The effect of the O-antigen in the lipopolysaccharide produced by the smooth phenocopy on the binding of antibody to the lambda receptor was determined. The smooth phenocopy exhibited significantly less binding of antibody than did the rough phenocopy. In addition, expression of the lambda receptor had little effect on the binding of antibody to the lambda receptor in the smooth phenocopy but caused significantly increased binding in the rough mutant. The results suggest that the increased resistance to the lethal action of normal human serum shown by the smooth phenocopy may be due to the blocking of antibody binding sites by the O-antigen of lipopolysaccharide, thereby preventing activation of the classical pathway of complement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039705      PMCID: PMC261254          DOI: 10.1128/iai.48.3.759-762.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  Role of the receptor for bacteriophage lambda in the functioning of the maltose chemoreceptor of Escherichia coli.

Authors:  G L Hazelbauer
Journal:  J Bacteriol       Date:  1975-10       Impact factor: 3.490

2.  THE BIOSYNTHESIS OF CELL WALL LIPOPOLYSACCHARIDE IN ESCHERICHIA COLI. I. THE BIOCHEMICAL PROPERTIES OF A URIDINE DIPHOSPHATE GALACTOSE 4-EPIMERASELESS MUTANT.

Authors:  A D ELBEIN; E C HEATH
Journal:  J Biol Chem       Date:  1965-05       Impact factor: 5.157

3.  A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.

Authors:  R J Roantree; L A Rantz
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

4.  [Studies on the immune bacteriolysis. XIV. Requirement of all nine components of complement for immune bacteriolysis].

Authors:  K Inoue; K Yonemasu; A Takamizawa; T Amano
Journal:  Biken J       Date:  1968-09

5.  Occurrence of the bacteriophage lambda receptor in some enterobacteriaceae.

Authors:  M Schwartz; L Le Minor
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

6.  Maltose transport in Escherichia coli K-12: involvement of the bacteriophage lambda receptor.

Authors:  S Szmelcman; M Hofnung
Journal:  J Bacteriol       Date:  1975-10       Impact factor: 3.490

7.  The effect of purified lipopolysaccharide on the bactericidal reaction of human serum complement.

Authors:  R J Allen; G K Scott
Journal:  J Gen Microbiol       Date:  1980-03

8.  Relationship between bactericidal action of complement and fluidity of cellular membranes.

Authors:  K Kato; Y Bito
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

9.  Determinants that increase the serum resistance of Escherichia coli.

Authors:  P W Taylor; M K Robinson
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

10.  Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.

Authors:  K A Joiner; C H Hammer; E J Brown; M M Frank
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

View more
  7 in total

1.  Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination.

Authors:  R E Mandrell; W D Zollinger
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

2.  Plasmid-associated resistance of Salmonella typhimurium to complement activated by the classical pathway.

Authors:  J L Vandenbosch; D K Rabert; G W Jones
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

3.  Protective effect of Porphyromonas gingivalis outer membrane vesicles against bactericidal activity of human serum.

Authors:  D Grenier; M Bélanger
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

4.  Resistance of a Tn4351-generated polysaccharide mutant of Porphyromonas gingivalis to polymorphonuclear leukocyte killing.

Authors:  C A Genco; R E Schifferle; T Njoroge; R Y Forng; C W Cutler
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

5.  Inactivation of human serum bactericidal activity by a trypsinlike protease isolated from Porphyromonas gingivalis.

Authors:  D Grenier
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

6.  Characterization of the susceptibility of Pseudomonas aeruginosa to complement-mediated killing: role of antibodies to the rough lipopolysaccharide on serum-sensitive strains.

Authors:  N L Schiller
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

7.  Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores.

Authors:  Dennis J Doorduijn; Dani A C Heesterbeek; Maartje Ruyken; Carla J C de Haas; Daphne A C Stapels; Piet C Aerts; Suzan H M Rooijakkers; Bart W Bardoel
Journal:  PLoS Pathog       Date:  2021-11-09       Impact factor: 7.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.